LOXL2 and SYVN1 cooperate across cellular compartments to drive liver hepatocellular carcinoma progression
Authors:
- 23 December 2025
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 797, 153201
Abstract
No abstract availableKeywords
Funding Information
- National College Students Innovation and Entrepreneurship Training Program (202410366015)
- Anhui Medical University (2023xkjT028)
- Natural Science Foundation of Anhui Province (2108085MH266)
- Natural Science Foundation of Anhui Province (1708085MH212)
This publication has 37 references indexed in Scilit:
- Global burden of liver disease: 2023 updateJournal of Hepatology, 2023
- Endoplasmic Reticulum Stress and Metabolism in Hepatocellular CarcinomaThe American Journal of Pathology, 2022
- Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasisCancer Communications, 2021
- The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanismEuropean Journal of Cancer, 2021
- Signaling pathways in hepatocellular carcinoma2021
- Study on the hepatocellular carcinoma model with metastasisGenes & Diseases, 2020
- Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver FibrosisHepatology, 2020
- Tumor Necrosis Factor Receptor–Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance c‐Myc Gene Expression and Protein StabilityHepatology, 2019
- Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinomaHepatology, 2014
- Mdm2 links genotoxic stress and metabolism to p53Protein & Cell, 2010